Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area

medRxiv(2020)10.1101/2020.05.19.20107482Source: DataRank Database

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 85 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access85 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (35)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (48)

Gregory M. Goldgof ORCID,Brian R. Shy ORCID,Andrew G. Levine ORCID,Joanna Balcerek ORCID,Sagar P. Bapat ORCID

Live enrichment

PubMed:32511477 OpenAlex:https://openalex.org/W3027097563

National Institutes of Health

Grant: 5R01HL105704-05

Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing

National Institutes of Health

Grant: 5R38HL143581-02

Enhancing Resident Investigation and Career Advancement in Cardiovascular and Pulmonary Science

NIAID NIH HHS

Grant: L40 AI140341

NHLBI NIH HHS

Grant: R01 HL105704

NHLBI NIH HHS

Grant: R38 HL143581

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/05/27/2020.05.19.20107482.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.05.19.20107482

repositoryhttps://doi.org/10.1101/2020.05.19.20107482

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32511477

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

SeroprevalenceSeroconversionAntibodyMedicineTiterNeutralizing antibodyVirologyBayCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyImmunoglobulin GImmunoglobulin MSerologyInternal medicineGeographyInfectious disease (medical specialty)DiseaseBiomedical and Clinical SciencesCoronaviruses610ArticleCoronaviruses Therapeutics and InterventionsEmerging Infectious DiseasesInfectious DiseasesGood Health and Well BeingClinical Research616Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being